Abstract
This paper investigates the effect of drug treatment on the standard within-host virus model, assuming that therapy occurs periodically. It is shown that eradication is possible under these periodic regimens, and we quantitatively characterize successful drugs or drug combinations, both theoretically and numerically. We also consider certain optimization problems, motivated for instance, by the fact that eradication should be achieved at acceptable toxicity levels to the patient. It turns out that these optimization problems can be simplified considerably, and this makes calculations of the optima a fairly straightforward task. All our results will be illustrated on an HIV model by means of numerical examples based on up-to-date knowledge of parameter values in the model.
Similar content being viewed by others
References
Bajaria, S.H., Webb, G., Kirschner, D.E., 2004. Predicting differential responses to structured treatment interruptions during HAART. Bull. Math. Biol. 66, 1093–1118.
Ball, C.L., Gilchrist, M.A., Coombs, D., 2007. Modeling within-host evolution of HIV: mutation, competition and strain replacement. Bull. Math. Biol. 69, 2361–2385.
Berman, A., Plemmons, R., 1994. Nonnegative Matrices in the Mathematical Sciences. SIAM, Philadelphia.
Bonhoeffer, S., Nowak, M.A., 1997. Pre-existence and emergence of drug resistance in HIV-1 infection. Proc. R. Soc. Lond. B 264, 631–637.
De Leenheer, P., Pilyugin, S.S., 2008 Multi-strain virus dynamics with mutations: a global analysis. Math. Med. Biol., to appear. (Preliminary version in arXiv:0707.4501/).
De Leenheer, P., Smith, H.L., 2003. Virus dynamics: a global analysis. SIAM J. Appl. Math. 63, 1313–1327.
Dixit, N.M., Perelson, A.S., 2004. Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay. J. Theor. Biol. 226, 95–109.
d’Onofrio, A., 2005. Periodically varying antiviral therapies: conditions for global stability of the virus free state. Appl. Math. Comput. 168, 945–953.
Earn, D.J.D., Dushoff, J., Levin, S.A., 2002. Ecology and evolution of the flu. Trends Ecol. Evol. 117, 334–340.
Ganem, D., Prince, A.M., 2004. Hepatitis B virus infection—natural history and clinical consequences. New Engl. J. Med. 350, 1118–1129.
Kirschner, D., Lenhart, S., Serbin, S., 1997. Optimal control of the chemotherapy of HIV. J. Math. Biol. 35, 775–792.
Krakovska, O., Wahl, L.M., 2007. Drug-sparing regimens for HIV combination therapy: benefits predicted for “drug coasting”. Bull. Math. Biol. 69, 2627–2647.
Larder, B., Darby, G., Richman, D.D., 1989. HIV with reduced sensitivity to zidovudine isolated during prolonged therapy. Science 243, 1731–1734.
Locarnini, S., Lai, C.-L., 2003. Hepatitis B Virus Guide. International Medical Press, London.
Molineaux, L., Dietz, K., 2000. Review of intra-host models of malaria. Parassitologia 41, 221–231.
Nowak, M.A., May, R.M., 2000. Virus Dynamics. Oxford University Press, New York.
Ortiz, G.M., et al., 2001. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. 98, 13288–13293.
Perelson, A.S., Nelson, P.W., 1999. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 41, 3–44.
Ribiero, R.M., Bonhoeffer, S., 2000. Production of resistant HIV mutants during antiretroviral therapy. Proc. Natl. Acad. Sci. 97, 7681–7686.
Richman, D.D., et al., 1994. J Nevirapine resistance mutations of HIV-1 selected during therapy. J. Virol. 68, 1660–1666.
Richman, D.D. (Ed.), 2004. Human Immunodeficiency Virus. International Medical Press, London.
Rong, L., Feng, Z., Perelson, A.S., 2007. Emergence of HIV-1 drug resistance during antiretroviral treatment. Bull. Math. Biol. 69, 2027–2060.
Siliciano, J.D., et al., 2003. Long term follow-up studies confirm the extraordinary stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9, 727–728.
Special issue on virology and clinical advances of HCV infection, 2006. Int. J. Med. Sci. 3.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by NSF grant DMS-0614651.
Rights and permissions
About this article
Cite this article
De Leenheer, P. Within-Host Virus Models with Periodic Antiviral Therapy. Bull. Math. Biol. 71, 189–210 (2009). https://doi.org/10.1007/s11538-008-9359-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-008-9359-5